The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.


Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.


Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Global Opioids Agonist Drugs Market, By Product Type (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone), Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Mar 2017

Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth Opioids are generally prescribed for treating pain. The opioid drug class includes morphine, hydrocodone, oxycodone, heroin, codeine, morphine

Coherent Market Insights
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, Conjugated Vaccines), Animal Type (Companion Animal, Livestock Animal), and Geography - Trends, Analysis, and Forecast till 2024

Published Date : Feb 2017

Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccin

Coherent Market Insights
Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum, Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community Centers), and Geography - Insights, Opportunity Analysis, and Industry Forecast 2024 - 2027

Published Date : Aug 2019

Malaria Vaccines – Paving the Way for a Malaria-free World Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led t

Coherent Market Insights
Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Trends, and Forecast 2019 - 2027

Published Date : Aug 2019

Anti-Suicide Drugs – Beacon Light of Life on the Horizon Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Ant

Coherent Market Insights
Phenylalanine Market, by Type (L-phenylalanine, D-Phenylalanine and DL-phenylalanine), by Application (Depression, Chronic Pain, and Vitiligo), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Phenylalanine is essential alpha amino acid, which functions to maintain adequate levels of monoamine neurotransmitters in the brain, thereby maintaining balanced moods. Deficiency of phenylalanine causes mental confusion, depression, reduc

Coherent Market Insights
Fallopian Tube Cancer Market, by Type of Treatment (Therapy and Surgery), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Cells in the body divide and grow to replace damaged and old cells. Cell growth is highly regulated and when sufficient amount of cells are produced to replace the old ones, the division of normal cells is stopped. Regulation error in the c

Coherent Market Insights
Lidocaine Patches Market by Strength of Active Ingredient (5%, 4%, and Others), by Adhesive Material (Aqueous and Non-Aqueous), by Application (Back Pain, Neck Pain, Shoulder Pain, Knees & Elbow Pain, and Others) by End User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Lidocaine is an aminoethylamide local and topical anesthetic medication, causing temporary numbness or loss of sensation in the area of application. Lidocaine blocks the voltage-gated sodium channels of nerve membranes, thereby preventing the generatio

Coherent Market Insights
Tamoxifen Market, by Dosage Form (Powder, Capsule, Oral Solution, and Tablets), by Indication (Breast Cancer and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormo

Coherent Market Insights
Coronary Artery Disease Therapeutics Market, by Drug Type (Beta Blockers, Calcium Channel Blockers, ACE Inhibitors, Nitrates, Statin, and Others), by End User, and by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Coronary Artery Disease (CAD) is a medical condition developed due to damaged or diseased blood vessels, which supply blood, nutrients, and oxygen to the heart. Coronary heart disease is characterized by deposition of cholesterol plague in the arteries, which results

Coherent Market Insights
Artificial Insemination Market, by Procedure Type (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, and Intratubal Insemination), by Product Type (Insemination Kits, Home Conception Devices, and Accessories), by End User, and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Artificial insemination is a medical process for the purpose of achieving pregnancy through intentional introduction of sperm in a female’s uterus by means other than sexual intercourse. Artificial insemination is a fertility treatment process for humans, and is

Coherent Market Insights
Diclofenac Patches Market, By Application (Lesions, Sprains and Strains), By End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Geography -Size, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Diclofenac is nonsteroidal anti-inflammatory drug (NSAID), which works in reducing hormones that cause inflammation and pain in the body. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used therapeutic class of analgesic compounds, indicated to use

Coherent Market Insights
Chronic Idiopathic Constipation (CIC) Treatment Market, By Drug Type (Linaclotide, Plecanatide, Lubiprostone, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region - Size, Share, Outlook and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Constipation is condition wherein the stool frequency reduces up to three times per week with difficulty in stool passing. Chronic constipation is a highly common functional gastrointestinal disorder that adversely affects patient’s life. Chronic idiopathic cons

Coherent Market Insights
Betaxolol Market, by Disease Indication (Glaucoma and Ocular Hypertension), by Dosage Form (Tablets and Suspension), by Distribution Channel, and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Betaxolol is a racemic mixture and beta-adrenergic receptor inhibitor used to treat patients with chronic open-angle glaucoma or ocular hypertension. It was first approved by the U.S. Food and Drug Administration (FDA) in 1989, as an oral tablet. Betaxolol is used eit

Coherent Market Insights
Erythromycin Market, by Formulation (Gel, Tablet, Topical Solution, Ointment, and Others), by Disease Indication (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections, and Others) by Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Erythromycin is an antibiotic, which is used to treat certain kind of bacterial infections. Erythromycin topical preparations are largely used on the skin to help control acne. The antibiotic is also used in combination with other medicines and are applied topically o

Coherent Market Insights
Malignant Ascites Treatment Market, by Treatment Type (Therapeutic Treatment and Surgical Treatment), by Application (Ovarian Cancer, Breast Cancer, Gastrointestinal Cancer, Colorectal Cancer, Carcinoma of Unknown Primary, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant periton

Coherent Market Insights
Cellulite Treatment Market, by Treatment Procedure (Non-invasive, Minimally-invasive, and Topical Treatment), by Cellulite (Soft Cellulite, Hard Cellulite, and Edematous Cellulite), by End User, and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Cellulite is a condition in which a person’s skin of their thighs, buttocks, and hips appears dimpled. Common names for cellulite include cottage cheese skin, orange-peel skin, hail damage, and the mattress phenomenon. This condition is commonly observed in wome

Coherent Market Insights
Blepharitis Treatment Market, By Disease Type (Posterior Blepharitis, Anterior Blepharitis, and Mixed Blepharitis), By Treatment Type (Antibiotic Therapy (Topical Corticosteroids, Topical Antibodies, and Oral Antibodies), Ointments, Eye Cleansers, and Others), By End User (Hospitals, Specialty Centers, and Others), By Region - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Nov 2019

Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of

Coherent Market Insights
Hunter Syndrome Treatment Market, by Treatment Type (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others), by End Users (Hospitals, Clinics, Specialty Care Unit, and Others), and by Geography - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Nov 2019

Hunter syndrome also called as Mucopolysaccaridosis type II (MPS II), is the disorder affecting several parts of the body. Hunter syndrome is inherited genetic disorder caused by a malfunctioning or missing enzyme. At birth hunter syndrome individuals do not display a

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.